Literature DB >> 15517370

Expression and localization of membrane-type-1 matrix metalloproteinase, CD 44, and laminin-5gamma2 chain during colorectal carcinoma tumor progression.

Shinji Murai1, Toshifumi Umemiya, Motoharu Seiki, Kenichi Harigaya.   

Abstract

Membrane-type-1 matrix metalloproteinase (MT1-MMP) is overexpressed in many malignant tumor tissues and would be involved in tumor-cell migration. Using dual immunofluorescence of frozen sections, this study examined the expression and localization of MT1-MMP and its interacting molecules, CD44 and laminin-5gamma2 chain (LN-5gamma2) monomer, in 48 cases of colorectal tumors. Recent studies have shown that MT1-MMP, CD44 and LN-5gamma2 are direct downstream targets in the adenomatosis polyposis coli (APC)/beta-catenin (Wnt)-signaling pathway, which is upregulated in most colorectal epithelial tumors. MT1-MMP overexpression was observed in adenocarcinoma cases with moderate and/or less differentiation coinciding with CD44 downmodulation. Recent observations indicate that MT1-MMP overexpression disrupts tubulogenesis of MDCK cells in type-I collagen-rich tissues. Therefore, MT1-MMP overexpression might involve disturbances of neoplastic glandular structures during colorectal adenocarcinoma tumor progression. Intensity distribution analyses of images with dual immunofluorescence indicated that overexpressed MT1-MMP is closely associated with the enhanced expression of the LN-5gamma2 monomers at the invasive front of dedifferentiated tumor cells. Additionally, the graded expression of nuclear active beta-catenin was found in moderately differentiated and dedifferentiated areas of adenocarcinomas, where MT1-MMP overexpression was observed. Therefore, this study reveals that MT1-MMP might be a major effector of Wnt signaling in the late stage of colorectal carcinoma tumor progression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15517370     DOI: 10.1007/s00428-004-1029-x

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  43 in total

1.  CD44 is required for two consecutive steps in HGF/c-Met signaling.

Authors:  Véronique Orian-Rousseau; Linfeng Chen; Jonathan P Sleeman; Peter Herrlich; Helmut Ponta
Journal:  Genes Dev       Date:  2002-12-01       Impact factor: 11.361

2.  Up-regulation of the ectodermal-neural cortex 1 (ENC1) gene, a downstream target of the beta-catenin/T-cell factor complex, in colorectal carcinomas.

Authors:  M Fujita; Y Furukawa; T Tsunoda; T Tanaka; M Ogawa; Y Nakamura
Journal:  Cancer Res       Date:  2001-11-01       Impact factor: 12.701

3.  beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer.

Authors:  T Brabletz; A Jung; S Dag; F Hlubek; T Kirchner
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

4.  Identification of c-MYC as a target of the APC pathway.

Authors:  T C He; A B Sparks; C Rago; H Hermeking; L Zawel; L T da Costa; P J Morin; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1998-09-04       Impact factor: 47.728

5.  APC mutations occur early during colorectal tumorigenesis.

Authors:  S M Powell; N Zilz; Y Beazer-Barclay; T M Bryan; S R Hamilton; S N Thibodeau; B Vogelstein; K W Kinzler
Journal:  Nature       Date:  1992-09-17       Impact factor: 49.962

6.  Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion.

Authors:  Q Yu; I Stamenkovic
Journal:  Genes Dev       Date:  1999-01-01       Impact factor: 11.361

7.  Expression of CD44R1 adhesion molecule in colon carcinomas and metastases.

Authors:  K K Tanabe; L M Ellis; H Saya
Journal:  Lancet       Date:  1993-03-20       Impact factor: 79.321

8.  The gamma 2 chain of kalinin/laminin 5 is preferentially expressed in invading malignant cells in human cancers.

Authors:  C Pyke; J Rømer; P Kallunki; L R Lund; E Ralfkiaer; K Danø; K Tryggvason
Journal:  Am J Pathol       Date:  1994-10       Impact factor: 4.307

9.  TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP.

Authors:  Y P Han; T L Tuan; H Wu; M Hughes; W L Garner
Journal:  J Cell Sci       Date:  2001-01       Impact factor: 5.285

10.  Distinct effects of two CD44 isoforms on tumor growth in vivo.

Authors:  M S Sy; Y J Guo; I Stamenkovic
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

View more
  6 in total

1.  The liberation of CD44 intracellular domain modulates adenoviral vector transgene expression.

Authors:  Cristhian J Ildefonso; Wesley S Bond; Azza R Al-Tawashi; Mary Y Hurwitz; Richard L Hurwitz
Journal:  J Biol Chem       Date:  2012-08-03       Impact factor: 5.157

2.  The Wnt/planar cell polarity protein-tyrosine kinase-7 (PTK7) is a highly efficient proteolytic target of membrane type-1 matrix metalloproteinase: implications in cancer and embryogenesis.

Authors:  Vladislav S Golubkov; Alexei V Chekanov; Piotr Cieplak; Alexander E Aleshin; Andrei V Chernov; Wenhong Zhu; Ilian A Radichev; Danhua Zhang; P Duc Dong; Alex Y Strongin
Journal:  J Biol Chem       Date:  2010-09-13       Impact factor: 5.157

Review 3.  Proteolytic and non-proteolytic roles of membrane type-1 matrix metalloproteinase in malignancy.

Authors:  Alex Y Strongin
Journal:  Biochim Biophys Acta       Date:  2009-05-04

Review 4.  Matrix metalloproteinases, T cell homing and beta-cell mass in type 1 diabetes.

Authors:  Alexei Y Savinov; Alex Y Strongin
Journal:  Vitam Horm       Date:  2009       Impact factor: 3.421

5.  Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion through targeting laminin-332 in head and neck squamous cell carcinoma.

Authors:  Takashi Kinoshita; Toyoyuki Hanazawa; Nijiro Nohata; Naoko Kikkawa; Hideki Enokida; Hirofumi Yoshino; Takeshi Yamasaki; Hideo Hidaka; Masayuki Nakagawa; Yoshitaka Okamoto; Naohiko Seki
Journal:  Oncotarget       Date:  2012-11

6.  Basal localization of MT1-MMP is essential for epithelial cell morphogenesis in 3D collagen matrix.

Authors:  Sarah A Weaver; Brit Wolters; Noriko Ito; Anna M Woskowicz; Kazuyo Kaneko; Yasuyuki Shitomi; Motoharu Seiki; Yoshifumi Itoh
Journal:  J Cell Sci       Date:  2014-01-24       Impact factor: 5.285

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.